In an exclusive interview with Christine Tan, Christophe Weber, CEO of Takeda, reveals his thoughts on the company's transformative $62 billion acquisition of Shire, its commitment to developing breakthrough medicines, and how Japan's largest pharmaceutical company is reshaping the future of drug development.
18. April | 06:00 | CNBC Europe | Managing Asia |
18. April | 06:30 | CNBC Europe | Managing Asia |
18. April | 07:00 | CNBC Europe | Managing Asia |
19. April | 01:30 | CNBC Europe | Managing Asia |
19. April | 03:30 | CNBC Europe | Managing Asia |